ROSETTE JOSEPH: Open Payments
NPI 1598457996 · ROCKINGHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,457 in 87 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $817 · 2025 $1,457
Food & beverage: $1,457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $585 |
| Vanda Pharmaceuticals Inc. | 15 | $260 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $171 |
| Supernus Pharmaceuticals, Inc. | 12 | $132 |
| Collegium Pharmaceutical, Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Indivior Inc. | 1 | $25 |
Products named: VRAYLAR, FANAPT, CAPLYTA, Qelbree, Jornay PM, REXULTI, AUSTEDO XR, COBENFY.
Industry payments across NC — which companies pay providers there.
